425 Summer Street,

Boston,

MA,

USA,

ZIP: 02210

Phone: +14157353289

The Covid-19 global pandemic presented Lab Operations and Facility Management leaders with a unique set of challenges to keep research operations going, and ensure EHS compliance, whilst staying one step ahead to prepare for organization’s expansion plans. The 4th LAFM Summit is the one and only industry-led summit for the Lab Ops, Asset Management, Lab IT and FM leaders in the life science community to share lessons learned in 2020 and 2021; allowing you to hear how your peers and senior leaders have adapted through radical changes to shockproof your operational strategy.

3 Days I 32 Speakers I 4 Workshops I 2 Streams I 1 Careers Evening

Prices:

Pharma and Biotech Pricing - Conference + 4 workshops: USD 4395.00,
Pharma and Biotech Pricing - Conference + 2 workshops: USD 3497.00,
Pharma and Biotech Pricing - conference only: USD 2599.00,
Solution and Service Provider Pricing - Conference + 4 Workshops: USD 5395.00,
Solution and Service Provider Pricing - Conference + 2 workshops: USD 4297.00,
Solution and Service Provider Pricing - conference only: USD 3199.00

URLs:

Tickets: https://go.evvnt.com/855637-2?pid=1052

Brochure: https://go.evvnt.com/855637-3?pid=1052

Krisha Panchalingam, Senior Manager Lab Operations, Abata Therapeutics, David Heiger, Associate VP Marketing, Agilent CrossLab Group, Jake Haworth, Associate Director Operations, Alloy Therapeutics, Kim Dougherty, Director, Laboratory Operations, Atalanta Therapeutics, Jose Azurdia, Assistant Director, Global Facilities and Services, Biomarin Pharmaceutical, Bill VanDeWeghe, President and Chief Executive Officer, Biosurplus, David Karakas, Director Procurement and Sourcing, Bluebird Bio, Cindy Novak, Senior Manager, Lab Computing Systems, BMS, Hasmik Mkrtchyan, Business Process Manager, Global Quality Lab Operations, Catalent, Javier Morell, iLS Global Platform, Managing Director, CBRE, Katie Winter, Global iLS Managing Director, CBRE, Jedd Skibo, Director, Global Category Procurement, Charles River Lab, Stuart Flannery, Associate Director, Global Category Procurement, Charles River Lab, David Garza, Director Global Procurement, Eli Lilly and Company, Paul Lee, Director, R and D Operations, Portfolio Enablement, Eli Lilly and Company, Eri McMullen, Site Operations Manager, Exosome Diagnostics, a Bio-Techne brand, Hal Schneider, Director, Assay Development, R and D Lab Manager, Foundation Medicine Inc, Adam Dropkin, Senior Manager, Operations, Fulcrum Therapeutics, Nick Dove, President Heritage, Global Partners, Tzveta Panayotova, Principal, Senior Laboratory Planner, HOK, Stephen Katz, Director of Facilities and Lab Operations, Jounce Therapeutics, Erika Whyte, Director of Facilities and Lab Operations, Kymera Therapeutics, Kevin Dushney, Vice President, Information Technology, Kymera Therapeutics, Gabriela Rodriguez, Vasquez Manager, Lab Operations, MOMA Therapeutics, Ben Person, Vice President, Global Marketing, Nuvolo, Ethan Smith, General Manager, Life Sciences, Nuvolo, Eddie Z Luchs, Facilities Director, Omniome, Inc, Senior Representative, Perkin Elmer, Steven Driver, Principle Engineer and Energy Program Director, Sanofi, Amanda Allen, Senior Director of Operations, Scorpion Therapeutics, Mark McCord-Amasis, Vice President, Real Estate and Facilities, SeaGen, Andres Moreno, Senior Manager Lab Operations, Simcere Innovation, Nathalie Bitar, Associate Director of East Coast Lab Operations, Ultragenyx Pharmaceutical, Priya Vijayakumar, Chief Executive Officer, WattIQ, Kerri Anderson, Manager, Laboratory Operations, Zentalis Pharmaceutical